White House asks Supreme Court to uphold Trump’s tariff powers
The government submitted a 49-page brief urging the high court to affirm Trump’s broad emergency levies.
White House asks Supreme Court to uphold Trump’s tariff powers Read More »
Uncategorized
Vaccine access disparity between states roils patients, providers
Recent changes to federal guidance for prescribing COVID-19 vaccinations have providers worried for what’s to come. “We have opened a door to not using science to guide care,” said one physician.
Vaccine access disparity between states roils patients, providers Read More »
States are ramping up AI regulation. How should healthcare respond?
Industry leaders should engage with state lawmakers on AI bills, given many legislators have limited experience in healthcare or AI, experts said at the HIMSS AI Leadership Strategy Summit.
States are ramping up AI regulation. How should healthcare respond? Read More »
After FDA Rejection, Lexicon’s Type 1 Diabetes Drug Hit With Another Regulatory Delay
An advisory committee last year found that Zynquista’s benefit-risk profile in type 1 diabetes was unfavorable due to cases of diabetic ketoacidosis.
After FDA Rejection, Lexicon’s Type 1 Diabetes Drug Hit With Another Regulatory Delay Read More »
FDA Revives Decades-Dormant Drug as Potential Autism Treatment
The agency has also pointed to the use of Tylenol and other acetaminophen products during pregnancy as potentially linked to neurological and developmental defects in children, following a press conference Monday in which President Donald Trump did the same.
FDA Revives Decades-Dormant Drug as Potential Autism Treatment Read More »
Much Maligned Manufacturing Site Trips Up Scholar Rock’s Spinal Muscular Atrophy Drug
In its rejection letter, the FDA flagged problems at a third-party fill-finish site owned by Novo Nordisk. Issues at this site have previously been investigated by the regulator.
Much Maligned Manufacturing Site Trips Up Scholar Rock’s Spinal Muscular Atrophy Drug Read More »
Ionis Heads to FDA As Antisense Therapy Aces Pivotal Study in Rare Neurological Disease
By improving gait stability, Ionis’ zilganersen could be “potentially disease modifying,” according to analysts at William Blair.
Ionis Heads to FDA As Antisense Therapy Aces Pivotal Study in Rare Neurological Disease Read More »
El interesante crecimiento de XRP
XRP es la moneda del proyecto Ripple y en el último año ha experimentado un crecimiento impresionante. Durante años, el precio de la moneda se mantuvo en un determinado nivel, y todo ello tenía que ver con la prolongada demanda judicial entre la SEC y XRP. Desde que el pr …
Los metales presentes en el vapor de los cigarrillos electrónicos desechables pueden suponer riesgos para la salud
Los cigarrillos electrónicos y vapeadores desechables, baratos y de colores brillantes, siguen ganando popularidad. Estos dispositivos convierten un líquido, que puede contener nicotina saborizada, en un vapor que las personas aspiran en cientos o miles de inhalaciones, lo que com&uacu …
Generan por vez primera tejido cardíaco mediante bioimpresión 3D
Actualmente, la ingeniería de tejidos cardíacos es una vía muy prometedora en la búsqueda de nuevas terapias cardiovasculares. Mediante esta técnica, se podrían fabricar pedazos de miocardio que se implantarían en la zona afectada del corazón d …
Generan por vez primera tejido cardíaco mediante bioimpresión 3D Read More »